Multi-Peptide Blends: What One Vial of Several Compounds Can and Cannot Tell You

A blend vial holds several compounds lyophilised together. That is a packaging decision rather than a chemical one, and it changes what the numbers on the label and the certificate can actually tell you. Most of the confusion around blends comes from reading a blend figure as though it described a single compound.

The number on the label is a sum

When a vial is described as 80mg, that is the total across every component, not the quantity of any one of them. KLOW 80mg is BPC-157 10mg, TB-500 10mg, GHK-Cu 50mg and KPV 10mg. GLOW 70mg is the same first three without the KPV.

So the largest number in the vial is not the compound most people assume. In both blends, GHK-Cu is roughly two-thirds of the total mass. Comparing a blend price against a single-compound price per milligram without accounting for that produces a meaningless figure — the general version of that trap is in comparing peptide prices per milligram.

Purity of a blend is not one number

An HPLC purity figure is the area of the main peak divided by the total area of everything the detector recorded. A blend has no single main peak. It has several, by design.

That makes a bare purity percentage on a blend certificate ambiguous at best. Ninety-eight per cent of what? If the integration treats the four component peaks as one combined main peak, the figure says something about the vial as a whole and nothing about whether the components are present in the intended ratio. If it treats one peak as the main and the rest as impurities, it is nonsense.

What a good blend certificate looks like

There are two defensible approaches, and both are more informative than a single number.

The first is per-component testing before blending: each compound analysed on its own, with its own identity and purity result, and the blend assembled from material that was already characterised. The second is a blend chromatogram in which each component is resolved as its own peak, identified by retention against a standard, with areas reported separately.

What is worth asking for in either case is the chromatogram rather than the summary. A blend of four compounds should show four resolved peaks; peaks that co-elute cannot be quantified separately no matter what the certificate says. Reading an HPLC chromatogram and what a third-party peptide test actually measures cover how to read one.

Mass spectrometry on a mixture

Identity is more tractable than purity here. A mass spectrum of a blend shows a parent mass for each component, and those masses are far enough apart to be unambiguous — BPC-157 at roughly 1419.5, TB-500 at 889.0, GHK-Cu as the copper complex at roughly 402.9. Finding all of the expected masses confirms every component is present. It does not establish the ratio between them, which needs quantitative work against known standards.

The copper complex is a special case

GHK-Cu is not a peptide in the ordinary sense but a coordination complex: a tripeptide with a copper ion bound to it. In a blend it brings that copper with it, and copper is a redox-active metal. That is worth knowing when a blend also contains a methionine- or tryptophan-containing component, because transition metals catalyse oxidation of exactly those residues.

Neither BPC-157 nor TB-500 contains methionine or tryptophan, so the common tissue blends are well behaved in this respect. It is a reason to think about composition rather than to assume any blend is equivalent to its parts stored separately. GHK and GHK-Cu covers what the copper does and does not change.

The least stable component sets the shelf life

A vial is as stable as the most fragile thing in it. Components cannot be stored under different conditions once they are in the same vial, and they cannot be reconstituted at different times. If one compound in a blend is the one sensitive to light, oxygen or repeat entry, the whole vial inherits that sensitivity. Storage and stability covers the variables.

You cannot unmix it

This is obvious and still worth stating. Once compounds are lyophilised together there is no practical way to recover them separately at the bench. Every component is reconstituted in the same solvent, at the same time, at a concentration fixed by the ratio in the vial. Where an experiment needs the components at independent concentrations, or one of them alone, the single-compound listings are the right starting point: BPC-157, TB-500, GHK-Cu, CJC-1295 without DAC and Ipamorelin are all stocked on their own.

Working out per-component concentration

The arithmetic is simple once the composition is known. Reconstituting an 80mg KLOW vial in 4mL gives a solution that is nominally 2.5mg/mL in BPC-157, 2.5mg/mL in TB-500, 12.5mg/mL in GHK-Cu and 2.5mg/mL in KPV — one dilution, four different concentrations. Net peptide content applies to each component, so the nominal figures sit above the actual peptide mass; net peptide content explains the gap.

What we stock

The blends are KLOW 80mg, GLOW 70mg, BPC-157 & TB-500 10mg, BPC-157 & TB-500 20mg and CJC-1295 & Ipamorelin 10mg, each with its composition stated on the product page and its certificate published on the certificates of analysis page. All are supplied for laboratory research use only, and we publish no dosing information, no protocols involving human or veterinary subjects, and no statements about what any component does in a person.